Bioxytran, Inc.
BIXT
$0.109
$0.000.00%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.30K | 5.20K | 34.70K | 13.50K | 10.00K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 4.30K | 5.20K | 34.70K | 13.50K | 10.00K |
|
|||||
Total Current Assets | 4.30K | 5.20K | 34.70K | 13.50K | 10.00K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 131.70K | 133.50K | 124.30K | 115.00K | 115.50K |
Total Assets | 136.10K | 138.70K | 159.00K | 128.60K | 125.50K |
|
|||||
Total Accounts Payable | -- | 147.60K | -- | 2.70K | 700.00 |
Total Accrued Expenses | 563.50K | 277.90K | 259.80K | 321.60K | 98.40K |
Short-term Debt | 1.26M | 1.09M | 933.60K | 839.00K | 972.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.02M | 411.00K | 50.20K | 65.20K | 44.20K |
Total Other Current Liabilities | 1.02M | 411.00K | 50.20K | 65.20K | 44.20K |
Total Current Liabilities | 2.84M | 1.93M | 1.24M | 1.23M | 1.12M |
|
|||||
Total Current Liabilities | 2.84M | 1.93M | 1.24M | 1.23M | 1.12M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 1.26M | 1.09M | 933.60K | 839.00K | 972.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.84M | 1.93M | 1.24M | 1.23M | 1.12M |
|
|||||
Common Stock & APIC | 17.52M | 17.09M | 17.29M | 16.55M | 16.00M |
Retained Earnings | -20.27M | -18.92M | -18.40M | -16.96M | -16.30M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -2.75M | -1.84M | -1.11M | -405.70K | -296.20K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 43.40K | 43.20K | 28.90K | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 43.40K | 43.20K | 28.90K | -- | -- |
|
|||||
Total Common Equity | -2.75M | -1.84M | -1.11M | -405.70K | -296.20K |
Total Preferred Equity | 43.40K | 43.20K | 28.90K | -- | -- |
Total Minority Interest | -- | -- | -- | -694.20K | -694.20K |
Total Equity | -2.71M | -1.79M | -1.08M | -1.10M | -990.40K |
|